Inverse gas chromatography standard solutions, device and method

    公开(公告)号:US11467142B2

    公开(公告)日:2022-10-11

    申请号:US16072065

    申请日:2017-01-20

    摘要: The invention relates to a standard solution for inverse gas chromatography and/or surface energy analysis; a volumetric container for preparing such a standard solution; a method of preparing such a standard solution for inverse gas chromatography and/or a surface energy analysis and a method of probing a solid sample. The standard solution comprises a series of three or more compounds of increasing carbon chain length of general formula (I): R—X wherein: for the three or more compounds R is a series of alkyl, a series of alkenyl or a series of alkynyl groups of increasing carbon chain length; and for all three or more compounds X is H, OH, CO2H, C(O)H, C(O)CH3, NH2, SH or halogen; and the relationship between carbon chain length and volume of the compounds of increasing carbon chain length of general formula (I) is determined by the following formula.

    METHOD FOR THE QUANTITATIVE CHARACTERIZATION OF AMYLOID AND/OR AGGREGATING PEPTIDES AND/OR PROTEINS IN A SAMPLE
    16.
    发明申请
    METHOD FOR THE QUANTITATIVE CHARACTERIZATION OF AMYLOID AND/OR AGGREGATING PEPTIDES AND/OR PROTEINS IN A SAMPLE 审中-公开
    在样品中定量表征淀粉样蛋白和/或聚集肽和/或蛋白质的方法

    公开(公告)号:US20160349273A1

    公开(公告)日:2016-12-01

    申请号:US14902754

    申请日:2014-06-25

    IPC分类号: G01N33/68 B01D15/32 G01N30/89

    摘要: A method for the quantitative characterization of amyloid and/or aggregated peptides and/or proteins in a sample, comprising: providing a sample, wherein the sample includes an amyloid and/or aggregated peptide and/or protein having at least one aggregate size and shape; adding an active ingredient to be analyzed to the sample solution; separating the amyloid and/or aggregated peptides and/or proteins are from one another according to their aggregate size and shape; optionally completely denaturing the amyloid and/or aggregated peptides and/or proteins of a particular fraction into monomer building blocks; determining the change in concentration of the peptide and/or protein building blocks in at least one fraction by comparison against control values without the active ingredient.

    摘要翻译: 一种用于定量表征样品中淀粉样蛋白和/或聚集的肽和/或蛋白质的方法,包括:提供样品,其中所述样品包括具有至少一个聚集体尺寸和形状的淀粉样蛋白和/或聚集的肽和/或蛋白质 ; 将待分析的活性成分加入到样品溶液中; 淀粉样蛋白和/或聚集的肽和/或蛋白质的分离根据它们的聚集体大小和形状彼此分离; 任选地使特定级分的淀粉样蛋白和/或聚集的肽和/或蛋白质完全变性成单体结构单元; 通过与没有活性成分的对照值进行比较,确定至少一个馏分中肽和/或蛋白质结构单元的浓度变化。

    In vitro method for determining drug permeability using immobilized artificial membrane chromatography
    17.
    发明申请
    In vitro method for determining drug permeability using immobilized artificial membrane chromatography 审中-公开
    使用固定化人造膜色谱法测定药物渗透性的体外方法

    公开(公告)号:US20050014280A1

    公开(公告)日:2005-01-20

    申请号:US10840469

    申请日:2004-05-05

    摘要: The present invention provides a method for determining drug permeability, wherein the method comprises, for each reference drug of at least two reference drugs having (i) the same ionization state at a given pH and (ii) a known drug permeability determined by the same drug permeability testing technique, the calculation of a metric related to retention time of each reference compound eluted from a liquid chromatography column having an immobilized artificial membrane functional group. Then, based on each metric and each known drug permeability, drug permeability is expressed as a function of the metric. The method may further comprise the calculation of the metric related to retention time for a further drug eluted from the liquid chromatography column, the further drug having the same ionization state at the given pH and an unknown drug permeability, and an assessment of drug permeability for the further drug, based on the metric for the further drug and the function.

    摘要翻译: 本发明提供了一种用于测定药物渗透性的方法,其中所述方法包括至少两种参考药物的每种参考药物,所述参考药物具有(i)在给定pH下具有相同的电离状态,以及(ii)由相同的 药物渗透性测试技术,计算与具有固定的人造膜官能团的液相色谱柱洗脱的每个参考化合物的保留时间相关的度量。 然后,基于每个度量和每个已知的药物渗透性,药物渗透性被表示为度量的函数。 该方法还可以包括与从液相色谱柱洗脱的另外药物的保留时间相关的度量的计算,所述另外的药物在给定pH下具有相同的电离状态和未知的药物通透性,以及药物通透性的评估 进一步的药物,基于进一步药物和功能的指标。

    INVERSE GAS CHROMATOGRAPHY STANDARD SOLUTIONS, DEVICE AND METHOD

    公开(公告)号:US20190033272A1

    公开(公告)日:2019-01-31

    申请号:US16072065

    申请日:2017-01-20

    IPC分类号: G01N30/89 G01N30/06

    摘要: The invention relates to a standard solution for inverse gas chromatography and/or surface energy analysis; a volumetric container for preparing such a standard solution; a method of preparing such a standard solution for inverse gas chromatography and/or a surface energy analysis and a method of probing a solid sample. The standard solution comprises a series of three or more compounds of increasing carbon chain length of general formula (I): R—X wherein: for the three or more compounds R is a series of alkyl, a series of alkenyl or a series of alkynyl groups of increasing carbon chain length; and for all three or more compounds X is H, OH, CO2H, C(O)H, C(O)CH3, NH2, SH or halogen; and the relationship between carbon chain length and volume of the compounds of increasing carbon chain length of general formula (I) is determined by the following formula.